Bo Xiao

发表

Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease

Bo Xiao, D. Merlin, 2012, Expert opinion on drug delivery.

Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases.

Bo Xiao, D. Merlin, Chunhua Yang, 2021, Advanced drug delivery reviews.

Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.

Yuejun Kang, Ying Wan, Bo Xiao, 2018, ACS nano.

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

S. Srinivasan, Bo Xiao, D. Merlin, 2016, Biomaterials.

GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Knockout of Ste 20-Like Proline / Alanine-Rich Kinase ( SPAK ) Attenuates Intestinal In fl ammation in Mice

Bo Xiao, E. Viennois, Yutao Yan, 2013 .

Knockout of Ste20-like proline/alanine-rich kinase (SPAK) attenuates intestinal inflammation in mice.

Bo Xiao, E. Viennois, Yutao Yan, 2013, The American journal of pathology.

PepT1 expressed in immune cells has an important role in promoting the immune response during experimentally induced colitis

Bo Xiao, D. Merlin, E. Viennois, 2013, Laboratory Investigation.

Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.

Huan Wang, Bo Xiao, D. Merlin, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.

Bo Xiao, D. Merlin, E. Viennois, 2013, Biomaterials.

Human α-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice

Xia Zhao, Bo Xiao, B. Kan, 2008, Molecular Cancer Therapeutics.

A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.

Jun Zhou, Bo Xiao, D. Merlin, 2016, Cancer research.

Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle.

Bo Xiao, D. Merlin, E. Viennois, 2014, Journal of materials chemistry. B.

Nanotherapeutics for Inflammatory Bowel Disease

Bo Xiao, D. Merlin, 2017 .

Intestinal Epithelial CD98 Directly Modulates the Innate Host Response to Enteric Bacterial Pathogens

D. Kalman, Bo Xiao, D. Merlin, 2013, Infection and Immunity.

Oral Administration of Hydrogel-Embedding Silk Sericin Alleviates Ulcerative Colitis through Wound Healing, Anti-Inflammation, and Anti-Oxidation.

F. Dai, Bo Xiao, Chunhua Yang, 2019, ACS biomaterials science & engineering.

Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model

P. Garg, Bo Xiao, D. Merlin, 2016, Cellular and molecular gastroenterology and hepatology.

Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer

P. Wang, Bo Xiao, D. Merlin, 2014, Laboratory Investigation.

Colonic miRNA Expression/Secretion, Regulated by Intestinal Epithelial PepT1, Plays an Important Role in Cell-to-Cell Communication during Colitis

Bo Xiao, D. Merlin, E. Viennois, 2014, PloS one.

Intestinal epithelial CD98 synthesis specifically modulates expression of colonic microRNAs during colitis.

Bo Xiao, D. Merlin, E. Viennois, 2012, American journal of physiology. Gastrointestinal and liver physiology.

expression of colonic microRNAs during colitis

Bo Xiao, D. Merlin, S. Sitaraman, 2012 .

Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.

Bo Xiao, D. Merlin, E. Viennois, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

PepT1 Expression Helps Maintain Intestinal Homeostasis by Mediating the Differential Expression of miRNAs along the Crypt-Villus Axis

P. Garg, Bo Xiao, D. Merlin, 2016, Scientific Reports.

Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.

T. Denning, Bo Xiao, D. Merlin, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans

Bo Xiao, D. Merlin, E. Viennois, 2017, Scientific Reports.

Longitudinal study of circulating protein biomarkers in inflammatory bowel disease.

Bo Xiao, D. Merlin, E. Viennois, 2015, Journal of proteomics.

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans

Bo Xiao, D. Merlin, E. Viennois, 2017, Scientific Reports.

Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.

T. Denning, Bo Xiao, D. Merlin, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Mo1740 Defects in Autophagy Favour Adherent-InvasiveE. coli Persistence Within Macrophages Leading to Increased PRO-Inflammatory Response

P. Garg, Bo Xiao, H. Laroui, 2012 .

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

S. Srinivasan, Bo Xiao, D. Merlin, 2016, Biomaterials.

Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.

Bo Xiao, D. Merlin, E. Viennois, 2013, Biomaterials.

Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer

Bo Xiao, D. Merlin, E. Viennois, 2016 .